Roberta Alfieri

11PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 26, 2025
Correction: Cavazzoni et al. Pemetrexed Enhances Membrane PD-L1 Expression and Potentiates T Cell-Mediated Cytotoxicity by Anti-PD-L1 Antibody Therapy in Non-Small-Cell Lung Cancer. <i>Cancers</i> 2020, <i>12</i>, 666.

Andrea Cavazzoni, Graziana Digiacomo, Roberta Alfieri

|Jan 21, 2023
A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC.

Maria Pia Adorni, Maricla Galetti, Silvia La Monica

|Dec 11, 2022
CDK4/6 Inhibition Enhances the Efficacy of Standard Chemotherapy Treatment in Malignant Pleural Mesothelioma Cells.

Rita Terenziani, Maricla Galetti, Silvia La Monica

|Feb 15, 2022
Reprogramming of Lipid Metabolism in Lung Cancer: An Overview with Focus on EGFR-Mutated Non-Small Cell Lung Cancer.

Kamal Eltayeb, Silvia La Monica, Marcello Tiseo

|Jul 24, 2021
Generation and Characterization of a New Preclinical Mouse Model of EGFR-Driven Lung Cancer with MET-Induced Osimertinib Resistance.

Maicol Mancini, Quentin-Dominique Thomas, Sylvia Bourdel

|Jul 02, 2021
Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells.

Valentina Coccè, Silvia La Monica, Mara Bonelli

Pageof 2

Frequent Collaborators

6 joint publications

Claudia Fumarola

6 joint publications

Silvia La Monica

5 joint publications

Maricla Galetti

4 joint publications

Andrea Cavazzoni